Myofibrillar myopathies: State of the art, present and future challenges. En savoir plus sur Myofibrillar myopathies: State of the art, present and future challenges.
A diagnostic flow chart for POLG-related diseases based on signs sensitivity and specificity. En savoir plus sur A diagnostic flow chart for POLG-related diseases based on signs sensitivity and specificity.
Clinical and electrophysiological features in a French family presenting with seipinopathy. En savoir plus sur Clinical and electrophysiological features in a French family presenting with seipinopathy.
Adult-onset autosomal dominant centronuClinique ear myopathy due to BIN1 mutations. En savoir plus sur Adult-onset autosomal dominant centronuClinique ear myopathy due to BIN1 mutations.
Testing the validity of a set of diagnostic criteria for sensory neuronopathies: a francophone collaborative study. En savoir plus sur Testing the validity of a set of diagnostic criteria for sensory neuronopathies: a francophone collaborative study.
Myofiber HLA-DR expression is a distinctive biomarker for antisynthetase-associated myopathy. En savoir plus sur Myofiber HLA-DR expression is a distinctive biomarker for antisynthetase-associated myopathy.
Whole-body musClinique e MRI to detect myopathies in non-extrapyramidal bent spine syndrome. En savoir plus sur Whole-body musClinique e MRI to detect myopathies in non-extrapyramidal bent spine syndrome.
Chronic inflammatory demyelinating polyradiculoneuropathy: search for factors associated with treatment dependence or successful withdrawal. En savoir plus sur Chronic inflammatory demyelinating polyradiculoneuropathy: search for factors associated with treatment dependence or successful withdrawal.
Rationale and efficacy of CD52 targeting in HTLV-1-associated myositis. En savoir plus sur Rationale and efficacy of CD52 targeting in HTLV-1-associated myositis.
Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin. En savoir plus sur Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin.